Please login or register first to view this content.
Drug News
Two Lots of COVID-19 Antiviral Drug Veklury Recalled
Keytruda Approved for Adjuvant Treatment IIB, IIC Melanoma Following Resection
Copiktra Indication for Relapsed/Refractory Follicular Lymphoma Withdrawn
Rinvoq Labeling Updated to Include Class Warnings Related to JAK Inhibitors
Early Data Suggest Potential Benefit of Heterologous Boosting for COVID-19
Monoclonal Antibody Therapy for COVID-19 Authorized for Children
Odds of SARS-CoV-2 Infection Down After Third BNT162b2 Dose
PRP Injections Do Not Ease Pain in Knee Osteoarthritis
Treatments Compared for Advanced Renal Cell Carcinoma
Guselkumab Improves Psoriatic Arthritis in Patients With Inadequate Response to TNFi
FDA Approves Rituxan Plus Chemotherapy for Certain Pediatric Hematologic Cancers
Luspatercept Under Review for Nontransfusion Dependent Beta Thalassemia
Prescription Digital Therapeutic Cleared for IBS-Associated Abdominal Pain
FDA Needs More Data on Plinabulin for Chemotherapy-Induced Neutropenia
Clinically Significant Improvements in Genital Psoriasis Observed With Apremilast
Daratumumab/Hyaluronidase-fihj With Carfilzomib, Dexamethasone Approved for Multiple Myeloma
Fenfluramine Gets Priority Review for Lennox-Gastaut Syndrome
CDC Issues Alert on Omicron Variant, Provides HCP Recommendations
